News
Medications like semaglutide and liraglutide may help to reduce the risk of heart attacks, strokes, and other major adverse ...
Bone broth has been having a moment. An increasing number of folks are including the ingredient as part of their diet, many ...
Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...
Experts explain how to reverse facial volume loss caused by the side effect of Ozempic, from fillers to microneedling and fat ...
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
IT ONCE boasted over five million subscribers and saw one million of us stepping onto the scales every year. But Weight ...
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...
A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...
Within six months, the drug reduced the risk of cardiovascular death by 50 and cut the risk of needing urgent treatment due to heart failure.
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...
CBS News - Video on MSN1d
Study compares effectiveness of popular weight loss drugsA new study from the New England Journal of Medicine compares two weight loss drugs, Tirzepatide and Semaglutide. CBS News medical contributor Dr. Celine Gounder breaks down the findings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results